Fennec Pharmaceuticals Inc (FENC)
Healthcare
Biotechnology
9.60 $
+0.2%
vs. previous close
Closing price · As of: 3. Aug 2026
Fennec Pharmaceuticals Inc (FENC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -12 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.7 | -1.9 | -2.1 | -3.6 | -7.8 | -9.1 | -16 | -14 | -18 | -17 | 27 | -12 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | 0.1 | 0.4 | 0.0 | 0.1 | 0.3 | 1.0 | 0.1 | |
| 0.6 | 0.1 | 0.6 | 1.5 | 1.8 | 2.7 | 2.8 | 4.0 | 4.2 | 5.4 | 5.1 | 7.0 | |
| 0.4 | -1.1 | 0.7 | 2.4 | 1.9 | 3.1 | 2.9 | 4.0 | 4.4 | – | – | – | |
| 0.1 | -0.1 | 0.0 | 1.0 | 0.1 | 0.6 | -0.7 | -0.1 | -0.5 | -8.2 | -7.3 | -15 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | 0.5 | – | – | – | |
| 2.3 | 0.5 | 5.1 | 28 | 2.3 | -0.1 | 32 | 0.0 | -0.2 | -0.1 | -0.2 | – | |
| – | – | – | – | 5.0 | 5.0 | 5.0 | 5.0 | 20 | 5.0 | -13 | -19 | |
| 2.3 | 0.5 | 5.1 | 28 | 2.3 | -0.1 | 32 | 5.0 | 21 | 6.6 | -14 | 23 | |
| 0.6 | -1.4 | 3.0 | 24 | -5.5 | -9.1 | 17 | -9.2 | 2.7 | -11 | 13 | 10 | |
| -1.7 | -1.9 | -2.1 | -3.6 | -7.8 | -9.1 | -16 | -14 | -18 | -17 | 27 | -12 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.